National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 6) (No. PB 36 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L01039

 
PB 36 of 2013
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 6)
 
National Health Act 1953
___________________________________________________________________________
 
I, Steve Dunlop, Acting Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated  13 June 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
STEVE DUNLOP
Acting Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
 
 
 
1              Name of Instrument
 
(1)                This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No.6).
 
(2)                This Instrument may also be cited as PB 36 of 2013.
 
2             Commencement
                This Instrument commences on 1 July 2013.
3              Amendments to PB 79 of 2011
                      Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).
 
 
Schedule 1                   Amendments
 
[1]    Section 3, Definition for diluent fee
omit:                    $4.83
substitute:          $4.91
[2]    Section 3, Definition for dispensing fee
omit:                    $6.52
substitute:          $6.63
[3]    Section 3, Definition for distribution fee
omit:                    $24.38
substitute:          $24.79
[4]    Section 3 Definition for preparation fee
omit:                    $40.64
substitute:          $101.33
 
[5]    Schedule 1 Part 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL with manner of administration Injection/intravesical:
omit:
 
Epirubicin SZ
HX
MP
 
D
 
 
 
[6]    Schedule 1 Part 1, entry for Irinotecan in the form I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL with manner of administration Injection:
omit:
 
Irinotecan SZ
HX
MP
C3184
D
 
 
 
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.comlaw.gov.au.
Read Entire Law on www.comlaw.gov.au